Nicolas Leupin insider trades

Open-market stock purchases and sales by Nicolas Leupin, Former Chief Medical Officer at NovoCure Ltd, from SEC Form 4 filings since Feb 27, 2024.

Recent trades

DateStockTradeValue
Mar 4, 2026NVCR NovoCure LtdSold$14.6K
Feb 27, 2026NVCR NovoCure LtdSold$14.1K

Companies traded

  • NVCR NovoCure Ltd: 6 sales, last Mar 4, 2026

Get free alerts when Nicolas Leupin files a new trade →